NeoCore Technology Co

NeoCore Technology Co Intangible Assets

The Intangible Assets of NeoCore Technology Co (4131.TWO) as of Nov 11, 2026 is 2.72 M TWD. In the previous year, Intangible Assets was 3.17 M TWD — a change of -14.11% (lower).

Intangible Assets

2.72 MTWD

YoY

-14.11%

Last updated:

Intangible Assets of NeoCore Technology Co is 2023 2.72 M TWD. Intangible Assets of NeoCore Technology Co was 2022 3.17 M TWD. It decreases by -14.11% lower compared to the previous year.

The NeoCore Technology Co Intangible Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Intangible Assets
Date
Intangible Assets
Jan 1, 2016
7.38 M TWD
Jan 1, 2017
6.67 M TWD
Jan 1, 2018
5.97 M TWD
Jan 1, 2019
5.26 M TWD
Jan 1, 2020
4.56 M TWD
Jan 1, 2021
3.86 M TWD
Jan 1, 2022
3.17 M TWD
Jan 1, 2023
2.72 M TWD
The NeoCore Technology Co Intangible Assets history
YEARIntangible AssetsYoY
2.72 MTWD-14.11%
3.17 MTWD-17.91%
3.86 MTWD-15.39%
4.56 MTWD-13.36%
5.26 MTWD-11.77%
5.97 MTWD-10.53%
6.67 MTWD-9.71%
7.38 MTWD-40.86%
12.49 MTWD-3.98%
13.00 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

NeoCore Technology Co Stock analysis

What does NeoCore Technology Co do? NeoCore Technology Co Ltd generates revenue through the sale of biochips and related biotechnology products. The company develops and manufactures DNA/RNA sample preparation kits, polymerase chain reaction kits, rapid hybridization equipment, biochips, testing reagents, biological preparations, nucleic acid sequencing detection systems, biotechnology control hardware and software, and biomedical materials. These products are primarily sold within Taiwan and exported to Asian and European markets. The company's domestic sales focus on the Taiwanese market while international exports target Asian and European customers. DR. Chip Biotechnology, Inc. operates as the parent company for NeoCore Technology Co Ltd, managing the research, development, manufacturing, and sales of biochips. The business model relies on direct sales of its comprehensive product portfolio to domestic and international clients in the biotechnology sector. The company's product range serves both laboratory and commercial applications within the biotechnology industry. NeoCore Technology Co Ltd's revenue streams include the sale of biochips, DNA/RNA sample preparation kits, polymerase chain reaction kits, and related components. The company's export focus on Asia and Europe drives international sales, while domestic sales in Taiwan form a significant portion of its business. The company's product offerings cater to the needs of biotechnology laboratories and commercial entities requiring advanced biotech solutions. NeoCore Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about NeoCore Technology Co stock

Intangible Assets of NeoCore Technology Co is 2.72 M TWD in 2023.

Intangible Assets of NeoCore Technology Co changed from 3.17 M TWD to 2.72 M TWD, representing a -14.11% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Intangible Assets NeoCore Technology Co since 2006 – with annual values, charts, and detailed analysis.

Intangible assets are non-physical assets such as patents, trademarks, copyrights, and software. They can be significant value drivers for technology and pharmaceutical companies.

Intangible Assets's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Intangible Assets's NeoCore Technology Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — NeoCore Technology Co

All Key Metrics — NeoCore Technology Co